prostate header graphic
Prostate Problem Guide

Prostate Cancer Stages In Simple Non-Medical Terms

It is extremely important that, following a diagnosis of prostate cancer, the stage and growth rate of the cancer is determined, so that the most suitable form of treatment can be given. This involves determining the spread of the cancer outside of the prostate gland and the manner in which the cancer is growing.

Prostate cancer cells are similar to other body cells in many ways and will go through various stages of growth and there are a number of tests and grading systems which can be used to determine and classify the stage of growth of prostate cancer cells.

A widely used method of grading is known as the Gleason system. In this case cancer cells are compared to normal cells and given a score to indicate their appearance when compared to normal cells. Grading runs from 1 to 5, with 1 representing a cell which is quite close to a normal cell and 5 indicating a cell which bears little resemblance to a normal cell.

Unfortunately cells in different areas of the prostate may be at different stages of development and so, in order to obtain an overall Gleason score, the scores are taken from the two areas which are most affected by cancer and the scores are then added together. This overall score, which will lie between 2 and 10, indicates an increasingly aggressive form of prostate cancer as the score increases.

A commonly used system in determining the extent to which cancer has spread is the TNM system, which uses a combination of the size of the tumor, the extent to which the lymph nodes have been affected and the presence of other related cancers appearing in sites other than the prostate gland.

Using the TNM system prostate cancer is then classified as being T1, T2, T3 or T4 cancer, with T1 and T2 indicating a cancer which is confined to the prostate gland and T3 and T4 indicating a cancer which has spread beyond the prostate gland.

Further information on prostate cancer stages:

PSA Test Reduces Prostate Cancer Deaths by 40% - PR Newswire (press release)


TopNews United States

PSA Test Reduces Prostate Cancer Deaths by 40%
PR Newswire (press release)
"The long-term solution is to discover a new biomarker for prostate cancer – without false positives or negatives and one that determines who has a ...
PSA Discoverer Says PSA Screening is "Public Health Disaster"Medscape
Prostate cancer and menHartford Courant (blog)
Inventor of prostate test calls screening a 'disaster'ABC7Chicago.com
JD Supra (press release) -The Progressive Pulse (blog) -Food Consumer
all 16 news articles »

Two Phase 3 Trials Of Sunitinib With Commonly Used Chemotherapies In Advanced ... - MarketWatch (press release)


RTT News

Two Phase 3 Trials Of Sunitinib With Commonly Used Chemotherapies In Advanced ...
MarketWatch (press release)
Breast cancer is the most common cancer and the leading cause of cancer-related death among women globally. Compared to early stage breast cancer, ...
Pfizer says Sutent breast cancer trials failReuters
Pfizer ends study on potential lung cancer drugThe Associated Press
Pfizer Disappointed In Phase III Study Results For 2 DrugsWall Street Journal
BusinessWeek
all 174 news articles »

Nuggets Expect Karl Back Quickly After Surgery - New York Times (blog)


Washington Post

Nuggets Expect Karl Back Quickly After Surgery
New York Times (blog)
He overcame prostate cancer in 2005. “Cancer is a vicious opponent,” Karl said Feb. 17, during a press conference that revealed his condition. ...
Dantley, Nuggets band together while Karl fights his fightNBA.com

all 218 news articles »